Disruption isn’t a word normally associated with clinical drug development, but nevertheless it is coming. We can feel the rumblings of it. New technologies and technology-enabled techniques for productivity in mainstream business applications are slowly making their way into the clinic. There are signals that drug development is starting to catch up with the general … Continue reading “Re-thinking Clinical Trials for the World of Crowdsourcing”
Author: Laurie Halloran
Laurie Halloran is the president and CEO of Halloran Consulting Group, which she founded in 1998. With over 25 years of experience in clinical affairs management with contract research organizations and biotechnology companies, Laurie is recognized as an industry expert in improving the organizational effectiveness of clinical research programs with a specialty in gap analysis and strategic planning.